These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 20101721)

  • 41. The amyloid hypothesis of Alzheimer's disease at 25 years.
    Selkoe DJ; Hardy J
    EMBO Mol Med; 2016 Jun; 8(6):595-608. PubMed ID: 27025652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.
    Belkacemi A; Ramassamy C
    Free Radic Biol Med; 2012 Feb; 52(3):593-600. PubMed ID: 22172527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models.
    Wirths O; Bayer TA
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():1-5. PubMed ID: 18184365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
    Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
    J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetically modified mice models for Alzheimer's disease.
    Sankaranarayanan S
    Curr Top Med Chem; 2006; 6(6):609-27. PubMed ID: 16712495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics.
    Hussain I
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):395-402. PubMed ID: 20522015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synaptic structure and function in transgenic APP mice.
    Ashe KH
    Ann N Y Acad Sci; 2000; 924():39-41. PubMed ID: 11193800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Searching for new animal models of Alzheimer's disease.
    Epis R; Gardoni F; Marcello E; Genazzani A; Canonico PL; Di Luca M
    Eur J Pharmacol; 2010 Jan; 626(1):57-63. PubMed ID: 19836370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.
    Citron M; Westaway D; Xia W; Carlson G; Diehl T; Levesque G; Johnson-Wood K; Lee M; Seubert P; Davis A; Kholodenko D; Motter R; Sherrington R; Perry B; Yao H; Strome R; Lieberburg I; Rommens J; Kim S; Schenk D; Fraser P; St George Hyslop P; Selkoe DJ
    Nat Med; 1997 Jan; 3(1):67-72. PubMed ID: 8986743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer's disease: epidemiology, genetics, and beyond.
    Wang XP; Ding HL
    Neurosci Bull; 2008 Apr; 24(2):105-9. PubMed ID: 18369390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
    Roher AE; Maarouf CL; Kokjohn TA
    J Alzheimers Dis; 2016; 50(3):645-58. PubMed ID: 26757189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease.
    Mori T; Koyama N; Tan J; Segawa T; Maeda M; Town T
    J Biol Chem; 2017 Jul; 292(27):11310-11325. PubMed ID: 28512130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isolation Housing Exacerbates Alzheimer's Disease-Like Pathophysiology in Aged APP/PS1 Mice.
    Huang H; Wang L; Cao M; Marshall C; Gao J; Xiao N; Hu G; Xiao M
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu116. PubMed ID: 25568286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From prion diseases to Alzheimer's disease.
    Hsiao KK
    J Neural Transm Suppl; 1997; 49():135-44. PubMed ID: 9266423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.